|
Originally published In Press as doi:10.1074/jbc.M000899200 on May 12, 2000
J. Biol. Chem., Vol. 275, Issue 30, 23362-23367, July 28, 2000
Phospholemman Is a Substrate for Myotonic Dystrophy Protein
Kinase*
J. Paul
Mounsey §,
J. Edward
John III ,
Steve M.
Helmke¶,
Erik W.
Bush¶,
John
Gilbert ,
Allen D.
Roses ,
M. Benjamin
Perryman¶,
Larry R.
Jones**, and
J. Randall
Moorman
From the Departments of Internal Medicine
(Cardiovascular Division), Molecular Physiology and Biological Physics,
University of Virginia, Charlottesville, Virginia 22908, ¶ Department of Medicine, Division of Cardiology, University of
Colorado Health Science Center, Denver, Colorado 80262, Departments of Internal Medicine (Neurology) and Neurobiology,
Duke University Medical Center, Durham, North Carolina 27710, and the ** Departments of Internal Medicine and Pharmacology, Krannert
Institute of Cardiology, Indiana University School of Medicine,
Indianapolis, Indiana 46202
The genetic abnormality in myotonic muscular
dystrophy, multiple CTG repeats lie upstream of a gene that
encodes a novel protein kinase, myotonic dystrophy protein kinase
(DMPK). Phospholemman (PLM), a major membrane substrate for
phosphorylation by protein kinases A and C, induces Cl currents
(ICl(PLM)) when expressed in Xenopus
oocytes. To test the idea that PLM is a substrate for DMPK, we measured
in vitro phosphorylation of purified PLM by DMPK. To assess
the functional effects of PLM phosphorylation we compared
ICl(PLM) in Xenopus oocytes expressing PLM
alone to currents in oocytes co-expressing DMPK, and examined the
effect of DMPK on oocyte membrane PLM expression. We found that PLM is
indeed a good substrate for DMPK in vitro. Co-expression of
DMPK with PLM in oocytes resulted in a reduction in
ICl(PLM). This was most likely a specific effect of
phosphorylation of PLM by DMPK, as the effect was not present in
oocytes expressing a phos( ) PLM mutant in which all potential
phosphorylation had been disabled by Ser Ala substitution. The
biophysical characteristics of ICl(PLM) were not changed by
DMPK or by the phos( ) mutation. Co-expression of DMPK reduced the expression of PLM in oocyte membranes, suggesting a possible mechanism for the observed reduction in ICl(PLM) amplitude. These
data show that PLM is a substrate for phosphorylation by DMPK and
provide functional evidence for modulation of PLM function by phosphorylation.
*
This work was supported by the National Institutes of Health
(to A. D. R., L. R. J., and J. R. M.),
the Muscular Dystrophy Association (to J. G., A. D. R.,
and J. R. M.), the Piton Foundation (to A. D. R.),
the American Heart Association Virginia Affiliate (to J. P. M.), an American Heart Association Established Investigator Award (to
J. R. M.), and the long term support of the Clinical Research
Unit, M01-RR-30, National Center for Research Resources, General
Clinical Research Centers Program, National Institutes of
Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Box 6012, MR4 Bldg.,
UVAHSC, Charlottesville, VA 22908. Tel.: 804-982-3367; Fax: 804-982-3162; E-mail: pmounsey@virginia.edu.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X.-Q. Zhang, J. Wang, L. L. Carl, J. Song, B. A. Ahlers, and J. Y. Cheung
Phospholemman regulates cardiac Na+/Ca2+ exchanger by interacting with the exchanger's proximal linker domain
Am J Physiol Cell Physiol,
April 1, 2009;
296(4):
C911 - C921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Lifshitz, M. Lindzen, H. Garty, and S. J. D. Karlish
Functional Interactions of Phospholemman (PLM) (FXYD1) with Na+,K+-ATPase: PURIFICATION OF {alpha}1/beta1/PLM COMPLEXES EXPRESSED IN PICHIA PASTORIS
J. Biol. Chem.,
June 9, 2006;
281(23):
15790 - 15799.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Lansbery, L. C. Burcea, M. L. Mendenhall, and R. W. Mercer
Cytoplasmic targeting signals mediate delivery of phospholemman to the plasma membrane
Am J Physiol Cell Physiol,
May 1, 2006;
290(5):
C1275 - C1286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Geering
FXYD proteins: new regulators of Na-K-ATPase
Am J Physiol Renal Physiol,
February 1, 2006;
290(2):
F241 - F250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-G. Jia, C. Donnet, R. C. Bogaev, R. J. Blatt, C. E. McKinney, K. H. Day, S. S. Berr, L. R. Jones, J. R. Moorman, K. J. Sweadner, et al.
Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice
Am J Physiol Heart Circ Physiol,
April 1, 2005;
288(4):
H1982 - H1988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kaliman, D. Catalucci, J. T. Lam, R. Kondo, J. C. P. Gutierrez, S. Reddy, M. Palacin, A. Zorzano, K. R. Chien, and P. Ruiz-Lozano
Myotonic Dystrophy Protein Kinase Phosphorylates Phospholamban and Regulates Calcium Uptake in Cardiomyocyte Sarcoplasmic Reticulum
J. Biol. Chem.,
March 4, 2005;
280(9):
8016 - 8021.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. M. A. van Herpen, R. J. A. Oude Ophuis, M. Wijers, M. B. Bennink, F. A. J. van de Loo, J. Fransen, B. Wieringa, and D. G. Wansink
Divergent Mitochondrial and Endoplasmic Reticulum Association of DMPK Splice Isoforms Depends on Unique Sequence Arrangements in Tail Anchors
Mol. Cell. Biol.,
February 15, 2005;
25(4):
1402 - 1414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Wetzel and K. J. Sweadner
Phospholemman expression in extraglomerular mesangium and afferent arteriole of the juxtaglomerular apparatus
Am J Physiol Renal Physiol,
July 1, 2003;
285(1):
F121 - F129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Feschenko, C. Donnet, R. K. Wetzel, N. K. Asinovski, L. R. Jones, and K. J. Sweadner
Phospholemman, a Single-Span Membrane Protein, Is an Accessory Protein of Na,K-ATPase in Cerebellum and Choroid Plexus
J. Neurosci.,
March 15, 2003;
23(6):
2161 - 2169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Crambert and K. Geering
FXYD Proteins: New Tissue-Specific Regulators of the Ubiquitous Na,K-ATPase
Sci. Signal.,
January 21, 2003;
2003(166):
re1 - re1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. Lee, M. K. Patel, D. J. Mistry, Q. Wang, S. Reddy, J. R. Moorman, and J. P. Mounsey
Abnormal Na channel gating in murine cardiac myocytes deficient in myotonic dystrophy protein kinase
Physiol Genomics,
January 15, 2003;
12(2):
147 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-Q. Zhang, A. Qureshi, J. Song, L. L. Carl, Q. Tian, R. C. Stahl, D. J. Carey, L. I. Rothblum, and J. Y. Cheung
Phospholemman modulates Na+/Ca2+ exchange in adult rat cardiac myocytes
Am J Physiol Heart Circ Physiol,
January 1, 2003;
284(1):
H225 - H233.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|